Tofacitinib Citrate Sustained?Release Tablets (gujie) – Wholesale & Retail (For Research Use Only)
$3.00
Tofacitinib Citrate Sustained?Release Tablets (11?mg ×?14) are extended-release oral tablets formulated for once?daily dosing. Produced by CSPC Ouyi Pharmaceutical under approval H20223760. Designed for laboratory and preclinical studies in JAK?STAT signaling modulation, immune suppression modeling, and chronic inflammation research. Wholesale and retail options available. For research use only.?For wholesale prices, other specifications and uses, please consult our staff?
描述
Each tablet contains 11?mg tofacitinib citrate in a sustained?release matrix designed to achieve stable plasma concentration over 24 hours. Tofacitinib is a selective Janus kinase (JAK1 and JAK3) inhibitor, disrupting inflammatory cytokine signaling pathways. Clinically used for autoimmune conditions like rheumatoid arthritis, psoriasis, and ulcerative colitis, in research these tablets serve to explore immune signaling, cytokine regulation, transplant rejection models, and chronic inflammatory mechanisms. Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. under Chinese approval H20223760, available in 14?tablet bottles or boxes. Strictly for laboratory research only.
Tofacitinib Citrate Sustained?Release Tablets Product Specifications
| Parameter | Detail |
|---|---|
| Product Name | Tofacitinib Citrate Sustained?Release Tablets |
| Strength | 11?mg per tablet |
| Package Size | 14 tablets per bottle or box |
| Dosage Form | Sustained?release film?coated tablet |
| Manufacturer | CSPC Ouyi Pharmaceutical Co., Ltd. |
| Approval Number | ???? H20223760 |
| Drug Standard Code | 86902770004632 |
| Barcode | 6971207200033 |
| CAS Number | 540737?29?9 |
| Molecular Formula & Weight | C??H??N?O?; approx. 504.5 g/mol |
Tofacitinib Citrate Sustained?Release Tablets Mechanism of Action & Research Applications
Tofacitinib citrate functions as a JAK1/JAK3 inhibitor, blocking downstream STAT activation and reducing signaling from pro-inflammatory cytokines. This mechanism is valuable in laboratory research modeling rheumatoid arthritis, ulcerative colitis, psoriasis, transplant rejection, and JAK?STAT pathway studies. The sustained-release formulation enables consistent exposure, supporting chronic dosing protocols and pharmacokinetics research in vitro or animal models.
Tofacitinib Citrate Sustained?Release Tablets Side Effects (For Reference Only in Research Models)
Experimental or clinical-analogue models may present increased infection markers due to immunosuppression, elevated blood pressure, changes in lipid profiles, gastrointestinal issues, headache, and rare thromboembolic events. These observations inform safety-first design in research dosing regimens.
Disclaimer
Tofacitinib Citrate Sustained?Release Tablets 11?mg are strictly intended for laboratory research use only. Not for human or veterinary therapeutic or diagnostic use.
其他信息
| 重量 | 1 公斤 |
|---|---|
| 尺寸 | 26 × 23 × 26 厘米 |
相关产品
-
Mycophenolate Sodium Enteric-Coated Tablets – For Laboratory Research Use Only
Ruiyirong Mycophenolate Sodium Enteric-Coated Tablets deliver 0.18g per tablet. Supplied in a 120-tablet bottle, approved under NMPA H20213232. For experimental research use only.?For wholesale prices, other specifications and uses, please consult our staff? $1.00 -
Thymopentin For Injection 10?mg per Vial – Wholesale & Retail (For Research Use Only)
Thymopentin For Injection is a sterile injectable pentapeptide (10?mg per vial) manufactured by Shanghai Huayuan (Ningxia) Shasa Pharmaceutical Co., Ltd., approved under H20067994. Intended for laboratory research applications involving immune modulation and infection models. Wholesale and retail available.?For wholesale prices, other specifications and uses, please consult our staff? $1.00 -
Hydrocortisone Sodium Succinate for Injection 100mg – For Laboratory Research Use Only
Hydrocortisone Sodium Succinate Injection offers a 100mg dose per vial, produced by JinYao Heping (Tianjin) Pharmaceutical Co., Ltd. Registered under China NMPA approval H20253863. Intended exclusively for laboratory experimental research use. Supports wholesale and retail orders.?For wholesale prices, other specifications and uses, please consult our staff? $3.00 -
Tacrolimus Capsules PROGRAF®) 1?mg – For Laboratory Research Use Only
PROGRAF® Tacrolimus Capsules are 1?mg each, supplied in a 100?capsule bottle. Produced under license from Astellas Ireland and packaged by Astellas China, approved by NMPA under J20150102. Intended exclusively for laboratory research use; wholesale and retail supported.?For wholesale prices, other specifications and uses, please consult our staff?
$1.00
评价
目前还没有评价